ZNF506 Activators
ZNF506 can enhance its function as a transcription factor through various intracellular signaling pathways. Forskolin, by increasing cAMP levels, indirectly activates protein kinase A (PKA), which can phosphorylate and thereby enhance the DNA binding activity of ZNF506, leading to its functional activation. Similarly, dibutyryl-cAMP, a cell-permeable analog of cAMP, also activates PKA and can promote the phosphorylation of ZNF506 to boost its transcriptional activity. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which can phosphorylate ZNF506, possibly altering its conformation and increasing its activity. Ionomycin raises intracellular calcium concentrations, which can activate calcium/calmodulin-dependent protein kinases (CaMKs); these kinases may directly phosphorylate ZNF506 or modify regulatory proteins that interact with it, leading to ZNF506 activation.
Epidermal Growth Factor (EGF) engages its receptor to initiate a cascade involving the Ras/Raf/MEK/ERK pathway, potentially leading to post-translational modifications of ZNF506 that enhance its transcriptional activity. Insulin, through its receptor, activates the PI3K/Akt signaling pathway, where Akt kinase can phosphorylate ZNF506, potentially modulating its activity. Calyculin A and Okadaic Acid, both inhibitors of protein phosphatases 1 and 2A, prevent the dephosphorylation of proteins, which could indirectly sustain the phosphorylation and hence the activation of ZNF506 by other kinases. Anisomycin stimulates stress-activated protein kinases (SAPKs) like JNK, which may also phosphorylate and activate ZNF506. Lastly, Trichostatin A, by inhibiting histone deacetylases and altering chromatin structure, may increase the accessibility of ZNF506 to its target genes, facilitating its activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC), which is involved in various signaling pathways. ZNF506, being a transcription factor, may have regulatory sites for PKC. The activation of PKC by PMA could result in the phosphorylation of ZNF506, leading to a conformational change that enhances its activity as a transcription factor. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Elevated calcium can activate calcium/calmodulin-dependent protein kinases (CaMKs), which could phosphorylate ZNF506 directly or target regulatory proteins that interact with ZNF506, leading to its activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the insulin receptor, leading to the activation of the PI3K/Akt signaling pathway. Akt can phosphorylate and modulate the activity of many proteins, including transcription factors. ZNF506, as a transcription factor, may have Akt phosphorylation sites, which, when phosphorylated, could enhance its transcriptional activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable cAMP analog that activates PKA. By activating PKA, dibutyryl-cAMP can mimic the activation of ZNF506 similar to that of forskolin, by promoting PKA-mediated phosphorylation that could enhance ZNF506 transcriptional activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which prevents the dephosphorylation of proteins, leading to increased phosphorylation status within the cell. This could lead to the phosphorylation and activation of ZNF506 by kinases such as PKA or PKC, as the inhibitory dephosphorylation events would be reduced. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Similar to calyculin A, okadaic acid is a potent inhibitor of PP1 and PP2A, leading to hyperphosphorylation of cellular proteins. This can indirectly lead to the activation of ZNF506 through enhanced phosphorylation by kinases that are positively regulating its activity. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases (SAPKs) like JNK. Activation of these kinases can lead to the phosphorylation of transcription factors. ZNF506 may be a substrate for these kinases, and its phosphorylation could result in its functional activation as a transcription factor. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of vitamin A, binds to its nuclear receptors and can regulate gene expression. Though not direct, retinoic acid can influence the expression and potentially the activity of transcription factors. ZNF506, as a member of the transcription factor family, may be positively influenced by retinoic acid-mediated signaling, affecting its activity through post-translational modification. | ||||||